Implantable Cardioverter-Defibrillator
Downloads
Introduction: Sudden cardiac death (SCD) is a public health problem with an incidence of 3 million worldwide. In most cases, it is secondary to heart rhythm disturbances of ventricular origin. The only treatment with proven efficacy is the implantation of an implantable cardioverter-defibrillator (ICD).
Materials and methods: We report a retrospective and descriptive study comprising 13 patients implanted with an ICD in our department and collected between 2010 and 2019.
Results: The average age of the patients is 44 years with a predominance of men. The distribution of etiologies shows a clear predominance of genetic heart disease. The symptomatology at implantation was mainly palpitations. 46% of patients in the series are implanted prophylactically. The single-chamber DAI is the most established (53.8%).
Conclusion: Our study first confirmed that ICD saves lives. It is the standard treatment for ventricular rhythm disorders, both in primary and secondary prevention of sudden death.
At the B cardiology department of the Rabat University Hospital, the general characteristics of the population studied are similar to those described in the literature with regard to the indications for implantation and patient follow-up are respected.
TISSEAU A., FAUCHIER L., PORET P., et al. Evaluation of the cost of complications of automatic implantable defibrillator. Arch Mal Coeur Vaiss,2007,100,9,P; 736-744
BBARDY GH., LEE KL., MARK DB., et al. Sudden Cardiac Death in Hert Failure trail ( SCD-HeFT) investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med, 2005, 352, p.225-237
BUXTON AE., LEE KL., FISHER JD., et al. A randomized study of the prevention of sudden death in patients with coronary artery diseases. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med, 1999, 341, p. 1882-1890
MOSS AJ., ZABERA W., HALL WJ., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection. N Engl J Med, 2002, 346, p. 877-883
HOHNLOSSER SH., KUCK KH., DORIAN P., et al. Prophylactic use of an implantable cardioverter defibrillator after acute myocardial infarction. N Engl J Med, 2004, 351, p.2481-2488
KADISH A., DYER A., DAUBERT JP., et al. For the defibrillators in non-ischemic cardiomyopathiy treatment evaluation (DEFINITE) investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med, 2004, 350, p. 2151-2158
ANSELME F., MLETZKO R., BOWES R., et al. Prevention of inappropriate shocks in ICD Recipients: A Review of 10000 Tachycardia Episode. Pace, 2007,30, p. 128-133
CATANZARO J., MAKARYUS A., SISON C., et al. Clinical Predictors of appropriate Implantable-Cardiovecter-Defibrillation Discharge. Pace, 2007 , 30, p. 120-124
CIGANKIEWICZ I., GILLESPIE J., ZAREBA W., et al. Preditors of long term mortality in Multicenter Automatic Defibrillators Implantation Trial II (MADIT II) patients with implantable cardioverter-defibrillator. Heart Rhythm,2009,4,p. 468-473
MOSS AL., HALL WJ., CANNOM DS., et al. Improved survival with an implanted defibrillator in patients with coronary disease at hign risk for ventricular arrhythmia
LE HEUZEY JY., MABO P., SADOUL N., et al. Death Causes in a Cohort of 2418 patients with an Implanted Defibrillator: The EVADEF Registry. Ciculation, 2006, 144,p 11-560
VAN DER VELDEN LB., HUYBRECHTS W., ADRIAENSENS B., et al. Appropriate and inapropriate implantable cardioverter defibrillator interventions during secondary prevention. Acta Cardiol, 2008,63,1,p. 39-45
Etat des lieux des poses de defibrillateurs automatiques implantables en 2016 et impact economique de l’arrivée des défibrillateurs sous-cutanes
Epstein AE, DiMarco JP, Ellenbogen KA, et al.F/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for devicebased therapy of cardiac rhythm abnormalities : A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice . Guidelines and the Heart Rhythm Society. J Am Coll. Cardiol 2013
DEFAYE P., JACON P. Complication du défibrillateur automatique implantable. MT Cardio, 2007, 3,3, p. 226-235
SINGH J., HALL J., Mc NITT S., et al. Factors influencing Appropriate firin of the Implanted defibrillator for ventricular Tachycardia/Fibrillation. Finding from the Multicenter automatic defibrillator implanation trial ( MADIT II). J Am Coll cardiol
BABUTY D., FAUCHIER L., CHARNIOT JC., et al. Complications à moyen terme du défibrillateur cardiaque automatique implantable. Arch Mal Coaur Vaiss, 2000, 93,11, p. 1269-1275
LIN G., NISHIMURA RA., GERSH BJ., et al. Device complications and Inappropriate Imloantable-Cardioverter-Defibrillator Shicks in Patients with hypertrophic Cadiomyopathy. Heart, 2009,
TSAI FS., ARONOW WS., DEVABHAKTUNI S., et al. Prevalence of Complication during implanation and during 38 month Follow-up of 1060 consecutive patient with implantable cardioverter defibrillator. Am J Ther, 2009, 28, p.
GLICKSON M., FRIEDMAN PA. The implantable cardioverter defibrillator. Lancet, 2001, 357, 9262, p. 1107-1117
DAUBERT JP., ZAIREBA W., CANNOM DS., et al. Inappropriate implantable cardioverter defibrillator schocks in MADIT II. Frequency, mechanism, predictors and survival impact. J Am Coll Cardiol, 2008, 8,51,14, p.1357-1365
MARIJON E., TRINQUART L., OTMANI A., et al. Competing risk analysis of cause specific mortality in patients with implantable cardioverter defibrillator: The EVADEF cohort study . Am Heart J, 2009, 157, 2, p. 391-397
SALUKHE T., DIMOPOULOS K., SUTTON R., et al. Life Years Gained From Defibrillator Implantation. Circulation, 2004,109, p. 1848-1853
STEIN KM., MITTAL S., GILLIAM FR., et al. Predictors of early mortality in implantable cardioverter-defibrillator reciprients. Europace, 2009
STOCKBURGER M., KREBS A., NITARDY A., et al. Survival and appropriate device interventions in recipients of cardioverter defibrillators implanted for the primary versus secondary prevention of sudden cardiac death. Pacing Clin Electrophysiol, 2009, 32,51,p. 516-520
THIBODEAU JB., PILLARISETTI J., KHUMRI TM., et al. Mortality rates and clinical predictors of reduced survival after cardioverter-defibrillateur implanation. Am J cardiol, 2008,15 p. 861-864
IRVINE J., DORIAN P., BAKER B., et al. Quality of the life in the Canadian Implanatble Defibrillator study (CIDS).
NOYES K., CORONA E., ZWANZIGER J., et al. Related Quality of life consequences of Implantable Cardioverter-Defibrillators : Results from MADIT II. Med Care,2007,45,5, p. 377-385
PASSMAN R., SUBACIUS H., RUO B., et al. Implatable Cardioverter Defibrillators and quality of life, results from the defibrillators in nonischemic cardiomyopathy treatment evaluation study. Arch intern Med, 2007,12,167, p. 2226-2232.
All Content should be original and unpublished.
